September 13, 2009

Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes

While not a peer-reviewed publications, Nephrology Now readers will likely be interested in this preliminary announcements of key findings of the TREAT study which looks at anemia treatment in CKD patients with diabetes.

Related Articles:

Anemia, Chronic Kidney Disease
  • Hallo, thanks for your help, your website is wonderfull, specialy for young moroccan nephrologiste like me … i want to know how can we evaluate the renal residual function before starting peritoneal function.